Gastroenterology Department, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, 3333 Bin Sheng Rd, Bin Jiang District, Hangzhou, Zhejiang, 310052, China.
Pathology Department, Zhejiang University School of Medicine and National Clinical Research Center for Child Health, Hangzhou, Zhejiang, China.
BMC Med Genomics. 2024 Jul 16;17(1):187. doi: 10.1186/s12920-024-01962-z.
With recent advances in gene sequencing technology, more than 60 genetic mutations associated with very early onset inflammatory bowel disease (VEO-IBD) have been reported. Most of the genes are associated with immune deficiencies. The Myosin 5B (MYO5B) gene is primarily involved in cell motility and material transport which is associated with congenital intractable diarrhea and cholestasis. No studies have examined the relationship between the MYO5B gene and VEO-IBD. We report a case of a child with a mutation in the MYO5B gene who was diagnosed with VEO-IBD, then we investigated the association between the MYO5B gene and VEO-IBD.
A 7-month-old baby girl with a chief complaint of "blood in the stool for more than 4 months and vaginal pus and blood discharge for 3 weeks" was diagnosed with VEO-IBD, and her symptoms improved after treatment with mesalazine. The whole-exome sequencing was performed with peripheral blood. Immunohistochemistry was performed on the terminal ileal tissue. Western blotting, quantitative polymerase chain reaction (Q-PCR) and immunofluorescence were performed with cultured organoid tissue from the terminal ileum. Whole-exome sequencing identified heterozygous missense of MYO5B variant of unknown significance (p. [I769N]; [T1546M]). Immunohistochemistry revealed a significant decrease in the expression of MYO5B protein in the terminal ileum of the child with MYO5B mutation; Q-PCR revealed a decrease in the mRNA levels of occludin and ZO-1 and both the mRNA levels and protein levels of MYO5B was downregulated in the patient. Immunofluorescence images showed that MYO5B gene mutation disrupted the apical delivery of transporters SGLT1, NHE3 and AQP7.
MYO5B gene mutation leading to the downregulation of MYO5B protein may promote the occurrence of VEO-IBD by decreasing mRNA and protein levels of intestinal tight junction genes and dislocating the apical transporters.
随着基因测序技术的最新进展,已经报道了 60 多种与早发性炎症性肠病(VEO-IBD)相关的基因突变。大多数基因与免疫缺陷有关。肌球蛋白 5B(MYO5B)基因主要参与细胞运动和物质运输,与先天性难治性腹泻和胆汁淤积有关。尚无研究探讨 MYO5B 基因与 VEO-IBD 之间的关系。我们报告了一例 MYO5B 基因突变患儿,该患儿被诊断为 VEO-IBD,然后我们研究了 MYO5B 基因与 VEO-IBD 之间的关系。
一名 7 个月大的女婴,主要抱怨“大便带血超过 4 个月,阴道脓液和血液排出 3 周”,被诊断为 VEO-IBD,经美沙拉嗪治疗后症状改善。进行外周血全外显子组测序。对末端回肠组织进行免疫组织化学染色。对末端回肠培养的类器官组织进行 Western blot、定量聚合酶链反应(Q-PCR)和免疫荧光染色。全外显子组测序发现 MYO5B 基因杂合错义变异,意义不明(p.[I769N];[T1546M])。免疫组织化学显示 MYO5B 基因突变患儿末端回肠 MYO5B 蛋白表达显著减少;Q-PCR 显示 occludin 和 ZO-1 的 mRNA 水平降低,MYO5B 的 mRNA 水平和蛋白水平下调;免疫荧光图像显示 MYO5B 基因突变破坏了 SGLT1、NHE3 和 AQP7 等转运体的顶端递呈。
MYO5B 基因突变导致 MYO5B 蛋白下调,可能通过降低肠道紧密连接基因的 mRNA 和蛋白水平以及使顶端转运体移位,促进 VEO-IBD 的发生。